A scintillation proximity assay for poly(ADP-ribose) polymerase

被引:14
|
作者
Cheung, A [1 ]
Zhang, J [1 ]
机构
[1] Guilford Pharmaceut Inc, Baltimore, MD 21224 USA
关键词
D O I
10.1006/abio.2000.4604
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribose) polymerase (PARP) is an abundant nuclear protein in most of the eukaryotic tissues. When activated by DNA damage, PARP synthesizes poly(ADP-ribose) from NAD, Conventional radioactive PARP enzyme assay requires the separation of the polymer product from the NAD substrate, a rate-limiting step that hampers large-scale chemical library screening to identify novel small-molecule PARP inhibitors. By using biotinylated NAD, we have developed a scintillation proximity assay (SPA) for PARP. We demonstrated that PARP can incorporate the biotinylated ADP-ribose units into the radioactive poly-(ADP-ribose) polymer, which can directly bind and excite the streptavidin-conjugated scintillation beads. PARP-SPA can be readily adapted to a 96-well format for automatic high-throughput screening for PARP inhibitors. (C) 2000 Academic Press.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [41] Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
    Smith, S
    Giriat, I
    Schmitt, A
    de Lange, T
    SCIENCE, 1998, 282 (5393) : 1484 - 1487
  • [42] POLY(ADP-RIBOSE) POLYMERASE - MOLECULAR BIOLOGICAL ASPECTS
    DEMURCIA, G
    MENISSIERDEMURCIA, J
    SCHREIBER, V
    BIOESSAYS, 1991, 13 (09) : 455 - 462
  • [43] Cleavage of poly(ADP-ribose) polymerase during apoptosis
    Soldani, C
    Lazzè, MC
    Bottone, MG
    Tognon, G
    Biggiogera, M
    Pellicciari, C
    Scovassi, AI
    PROCEEDINGS OF THE 5TH MULTINATIONAL CONGRESS ON ELECTRON MICROSCOPY, 2001, : 135 - 136
  • [44] Apoptosis in the absence of poly-(ADP-ribose) polymerase
    Leist, M
    Single, B
    Kunstle, G
    Volbracht, C
    Hentze, H
    Nicotera, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (02) : 518 - 522
  • [45] Activation of topoisomerase I by poly [ADP-ribose] polymerase
    Bauer, PI
    Buki, KG
    Comstock, JA
    Kun, E
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 5 (05) : 533 - 540
  • [46] CHARACTERIZATION OF HUMAN POLY(ADP-RIBOSE) POLYMERASE WITH AUTOANTIBODIES
    YAMANAKA, H
    PENNING, CA
    WILLIS, EH
    WASSON, DB
    CARSON, DA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (08) : 3879 - 3883
  • [47] STRUCTURAL REQUIREMENTS FOR INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE
    SESTILI, P
    SPADONI, G
    BALSAMINI, C
    SCOVASSI, I
    CATTABENI, F
    DURANTI, E
    CANTONI, O
    HIGGINS, D
    THOMSON, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) : 615 - 622
  • [48] Ubiquitination of poly (ADP-ribose) polymerase-1
    Wang, T
    Simbulan-Rosenthal, CM
    Smulson, ME
    Yang, DCH
    FASEB JOURNAL, 2003, 17 (04): : A182 - A183
  • [49] Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy
    Miller, Rowan E.
    CANCER JOURNAL, 2021, 27 (06): : 506 - 510